BIOA BioAge Labs, Inc. - Common Stock
$10.85
价格 · 八月 19, 2026
截至...的财报数据 八月 5, 2026
52周区间
$4–$26
30% of range
分析师评级
STRONG BUY
15 analysts
目标价
$36
+228% upside
P/E (TTM)
-5.8
ROE
-28.4%
净利润率
-896.1%
BIOA 股票快照 价格、市值、P/E、EPS、ROE、负债/权益、52周范围
价格
$10.85
市值
$482M
P/E (TTM)
-5.8
每股收益 (TTM)
$-2.24
营收 (TTM)
$9M
股息收益率
—
ROE
-28.4%
负债/权益
0.0
52周区间
$4 – $26
BIOA 股价图表 包含技术指标的日 OHLCV — 平移、缩放和自定义您的视图
Configure
10年表现 收入、净利润、利润率和每股收益趋势
营收与净利润
$9M
2024-12-31
→
2025-12-31
EPS
$-2.24
2023-12-31
→
2025-12-31
自由现金流
$-82M
2024-12-31
→
2025-12-31
利润率
-896.1%
估值 P/E、P/S、P/B、EV/EBITDA 比率 — 该股票是昂贵还是便宜？
指标
5年趋势
BIOA
同行中位数
P/E (TTM)
-5.8
11.7
P/S (TTM) (市销率 (TTM))
53.5
5.4
P/B (市净率)
1.8
3.7
EV / EBITDA (企业价值 / EBITDA)
-2.2
—
Price / FCF (股价/自由现金流)
-5.8
—
盈利能力 毛利率、营业利润率和净利率；股本回报率 (ROE)、资产回报率 (ROA)、投入资本回报率 (ROIC)
指标
5年趋势
BIOA
同行中位数
Operating Margin (营业利润率)
-1031.5%
—
Net Profit Margin (净利润率)
-896.1%
-45.6%
ROA
-24.7%
-25.4%
ROE
-28.4%
-27.1%
ROIC
-33.8%
—
财务健康 债务、流动性、偿付能力 — 资产负债表强度
指标
5年趋势
BIOA
同行中位数
Debt / Equity (负债/股东权益比率)
0.0
—
Current Ratio (流动比率)
14.2
4.6
Quick Ratio (速动比率)
14.0
—
成长 营收、每股收益 (EPS) 和净利润增长：同比、3年复合年增长率 (CAGR)、5年复合年增长率 (CAGR)
指标
5年趋势
BIOA
同行中位数
资本效率 资产周转率、库存周转率、应收账款周转率
指标
5年趋势
BIOA
同行中位数
BIOA 分析师共识 看涨和看跌分析师观点、12个月价格目标、上涨空间
买入
15 位分析师
- 强烈买入 6 40.0%
- 买入 6 40.0%
- 持有 3 20.0%
- 卖出 0 0.0%
- 强烈卖出 0 0.0%
12个月价格目标
8 位分析师 · 2026-08-17
中位数
$30.00
平均值
$35.62
← 低于所有目标
$10.85
最低
$20.00
最高
$73.00
中位数目标
$30.00
+176.5%
平均目标
$35.62
+228.3%
收益历史 每股收益实际值 vs 预估值，惊喜%，达标率，下次财报日期
平均惊喜
0.07%
| 期间 | EPS Actual | EPS 预期 | 惊喜 |
|---|---|---|---|
| 2026年6月30日 | $-0.58 | $-0.62 | 0.04% |
| 2026年3月31日 | $-0.52 | $-0.65 | 0.13% |
| 2025年12月31日 | $-0.72 | $-0.75 | 0.03% |
| 2025年9月30日 | $-0.56 | $-0.60 | 0.04% |
| 2025年6月30日 | $-0.60 | $-0.49 | -0.11% |
| 2025年3月31日 | $-0.36 | $-0.54 | 0.18% |
| 2024年12月31日 | $-1.97 | $-2.12 | 0.15% |
同行比较（GICS 子行业） 关键指标与行业同行对比
| 股票代码 | 市值 | P/E | 营收同比增长 | 净利润率 | ROE | 毛利率 |
|---|---|---|---|---|---|---|
| BIOA | $495M | -5.9 | — | -896.1% | -28.4% | — |
| CTNM | — | -5.3 | — | — | -27.7% | — |
| EOLS | $432M | -8.3 | 11.6% | -17.4% | 247.3% | 66.3% |
| AQST | $788M | -8.3 | -22.6% | -188.1% | 157.7% | — |
| RLMD | $354M | -3.3 | 93.7% | — | -112.0% | — |
| AVIR | $279M | -1.8 | — | — | -49.5% | — |
| LLY | — | 46.8 | 44.7% | 31.7% | 101.2% | — |
完整基本面 所有年度指标 — 损益表、资产负债表、现金流量表
损益表 14
| 指标 | 趋势 | 2025 | 2024 |
|---|---|---|---|
| Revenue | $9M | $0 | |
| R&D Expense | $74M | $59M | |
| SG&A Expense | $28M | $19M | |
| Operating Expenses | $102M | $78M | |
| Operating Income | $-93M | $-78M | |
| Other Non-op | $12M | $7M | |
| Pretax Income | $-81M | $-71M | |
| Income Tax | $0 | $0 | |
| Net Income | $-81M | $-71M | |
| EPS (Basic) | $-2.24 | $-6.63 | |
| EPS (Diluted) | $-2.24 | $-6.63 | |
| Shares (Basic) | 35,932,914 | 10,726,521 | |
| Shares (Diluted) | 35,932,914 | 10,726,521 | |
| EBITDA | $-93M | $-78M |
资产负债表 23
| 指标 | 趋势 | 2025 | 2024 |
|---|---|---|---|
| Cash & Equivalents | $189M | $354M | |
| Short-term Investments | $92M | $0 | |
| Receivables | $769.0K | $0 | |
| Prepaid Expense | $5M | $3M | |
| Current Assets | $287M | $357M | |
| PP&E (Net) | $963.0K | $591.0K | |
| PP&E (Gross) | $1M | $962.0K | |
| Accum. Depreciation | $482.0K | $371.0K | |
| Other Non-current Assets | $216.0K | $240.0K | |
| Total Assets | $295M | $358M | |
| Accounts Payable | $3M | $2M | |
| Current Liabilities | $20M | $28M | |
| Capital Leases | $2M | $0 | |
| Total Liabilities | $23M | $35M | |
| Long-term Debt | $3M | $9M | |
| Total Debt | $3M | $9M | |
| Common Stock | $0 | $0 | |
| Paid-in Capital | $605M | $576M | |
| Retained Earnings | $-333M | $-253M | |
| AOCI | $278.0K | $245.0K | |
| Stockholders' Equity | $272M | $323M | |
| Liabilities + Equity | $295M | $358M | |
| Shares Outstanding | 37,386,908 | 35,850,037 |
现金流 10
| 指标 | 趋势 | 2025 | 2024 |
|---|---|---|---|
| Stock-based Comp | $12M | $7M | |
| Operating Cash Flow | $-82M | $-52M | |
| CapEx | $719.0K | $366.0K | |
| Investing Cash Flow | $-95M | $-366.0K | |
| Stock Issued | $17M | $0 | |
| Net Stock Activity | $17M | · | |
| Financing Cash Flow | $11M | $381M | |
| Net Change in Cash | $-165M | $329M | |
| Taxes Paid | $0 | $0 | |
| Free Cash Flow | $-82M | $-52M |
盈利能力 7
| 指标 | 趋势 | 2025 | 2024 |
|---|---|---|---|
| Operating Margin | -1031.5% | · | |
| Net Margin | -896.1% | · | |
| Pretax Margin | -896.1% | · | |
| EBITDA Margin | -1031.5% | · | |
| ROA | -24.7% | -37.0% | |
| ROE | -28.4% | -22.3% | |
| ROIC | -33.8% | -23.6% |
流动性与偿付能力 4
| 指标 | 趋势 | 2025 | 2024 |
|---|---|---|---|
| Current Ratio | 14.2 | 12.9 | |
| Quick Ratio | 14.0 | 12.8 | |
| Debt / Equity | 0.0 | 0.0 | |
| LT Debt / Equity | 0.0 | 0.0 |
效率 2
| 指标 | 趋势 | 2025 | 2024 |
|---|---|---|---|
| Asset Turnover | 0.0 | · | |
| Receivables Turnover | 23.4 | · |
估值 (TTM) 14
| 指标 | 趋势 | 2025 | 2024 |
|---|---|---|---|
| Revenue TTM | $9M | $0 | |
| Net Income TTM | $-81M | $-71M | |
| Market Cap | $495M | $208M | |
| Enterprise Value | $216M | $-138M | |
| P/E | -5.9 | -0.9 | |
| P/S | 55.0 | · | |
| P/B | 1.8 | 0.6 | |
| P / Tangible Book | 1.8 | 0.6 | |
| P / Cash Flow | -6.1 | -4.0 | |
| P / FCF | -6.0 | -4.0 | |
| EV / EBITDA | -2.3 | 1.8 | |
| EV / FCF | -2.6 | 2.7 | |
| EV / Revenue | 24.0 | · | |
| Earnings Yield | -16.9% | -114.5% |
损益表 12
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $2M | $3M | $3M | $2M | $2M | $1M | $0 | $0 | $0 | |
| R&D Expense | $24M | $20M | $24M | $19M | $20M | $11M | $19M | $20M | $10M | |
| SG&A Expense | $7M | $8M | $7M | $7M | $7M | $7M | $6M | $5M | $5M | |
| Operating Expenses | $32M | $28M | $32M | $25M | $27M | $18M | $25M | $25M | $15M | |
| Operating Income | $-29M | $-25M | $-28M | $-23M | $-25M | $-16M | $-25M | $-25M | $-15M | |
| Other Non-op | $3M | $3M | $2M | $3M | $3M | $4M | $4M | $1M | $2M | |
| Net Income | $-26M | $-22M | $-26M | $-20M | $-22M | $-13M | $-21M | $-23M | $-14M | |
| EPS (Basic) | $-0.58 | $-0.52 | $-0.72 | $-0.56 | $-0.60 | $-0.36 | $15.77 | $-6.70 | $-7.94 | |
| EPS (Diluted) | $-0.58 | $-0.52 | $-0.72 | $-0.56 | $-0.60 | $-0.36 | $15.77 | $-6.70 | $-7.94 | |
| Shares (Basic) | 44,838,893 | 42,480,488 | -71,617,197 | 35,850,037 | 35,850,037 | 35,850,037 | 3,847,464 | 3,494,580 | 1,711,005 | |
| Shares (Diluted) | 44,838,893 | 42,480,488 | -71,617,197 | 35,850,037 | 35,850,037 | 35,850,037 | 3,847,464 | 3,494,580 | 1,711,005 | |
| EBITDA | $-29M | $-25M | · | $-23M | $-25M | $-16M | · | $-25M | · |
资产负债表 23
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $74M | $242M | $189M | $216M | $220M | $257M | $354M | $334M | · | |
| Short-term Investments | $245M | $141M | $92M | $70M | $77M | $63M | $0 | · | · | |
| Receivables | $625.0K | $709.0K | $769.0K | $515.0K | $603.0K | $361.0K | $0 | · | · | |
| Prepaid Expense | $11M | $8M | $5M | $5M | $4M | $4M | $3M | $2M | · | |
| Current Assets | $330M | $392M | $287M | $291M | $302M | $325M | $357M | $336M | · | |
| PP&E (Net) | $1M | $1M | $963.0K | $973.0K | $974.0K | $929.0K | $591.0K | $543.0K | · | |
| PP&E (Gross) | $2M | $2M | $1M | $1M | $1M | $1M | $962.0K | $1M | · | |
| Accum. Depreciation | $613.0K | $543.0K | $482.0K | $413.0K | $462.0K | $408.0K | $371.0K | $540.0K | · | |
| Other Non-current Assets | $208.0K | $215.0K | $216.0K | $227.0K | $237.0K | $239.0K | $240.0K | · | · | |
| Total Assets | $397M | $398M | $295M | $305M | $322M | $344M | $358M | $337M | · | |
| Accounts Payable | $6M | $3M | $3M | $5M | $1M | $4M | $2M | $2M | · | |
| Current Liabilities | $19M | $16M | $20M | $24M | $23M | $24M | $28M | $19M | · | |
| Capital Leases | $2M | $2M | $2M | $2M | $3M | $3M | $0 | · | · | |
| Total Liabilities | $22M | $19M | $23M | $28M | $27M | $31M | $35M | $24M | · | |
| Long-term Debt | · | · | $3M | $4M | $6M | $7M | $9M | $10M | · | |
| Total Debt | $0 | $1M | · | $4M | $6M | $7M | · | $10M | · | |
| Common Stock | $0 | $0 | $0 | $0 | $0 | · | $0 | · | · | |
| Paid-in Capital | $757M | $735M | $605M | $585M | $582M | $579M | $576M | $545M | · | |
| Retained Earnings | $-382M | $-356M | $-333M | $-307M | $-287M | $-266M | $-253M | $-232M | · | |
| AOCI | $-478.0K | $73.0K | $278.0K | $275.0K | $212.0K | $264.0K | $245.0K | $109.0K | · | |
| Stockholders' Equity | $375M | $379M | $272M | $277M | $295M | $313M | $323M | $314M | · | |
| Liabilities + Equity | $397M | $398M | $295M | $305M | $322M | $344M | $358M | $337M | · | |
| Shares Outstanding | 45,776,902 | 44,386,785 | 37,386,908 | 35,850,037 | 35,850,037 | 35,850,037 | 35,850,037 | 34,196,821 | · |
现金流 7
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $4M | $4M | $3M | $3M | $3M | $3M | $3M | $2M | $2M | |
| Operating Cash Flow | $-19M | $-24M | $-28M | $-16M | $-20M | $-17M | $-5M | $-15M | $-16M | |
| CapEx | $328.0K | $26.0K | $112.0K | $22.0K | $159.0K | $426.0K | $26.0K | $305.0K | $35.0K | |
| Investing Cash Flow | $-165M | $-47M | $-14M | $13M | $-16M | $-78M | $-26.0K | $-305.0K | $-35.0K | |
| Financing Cash Flow | $16M | $124M | $16M | $-2M | $-2M | $-2M | $25M | $191M | $-2M | |
| Net Change in Cash | $-168M | $53M | $-27M | $-5M | $-37M | $-97M | $20M | $175M | $-18M | |
| Free Cash Flow | · | $-24M | · | · | · | $-18M | · | · | · |
盈利能力 5
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -1196.8% | -915.4% | · | -1126.6% | -1027.0% | -1133.4% | · | · | · | |
| Net Margin | -1064.8% | -802.8% | · | -982.0% | -894.0% | -891.0% | · | · | · | |
| EBITDA Margin | -1196.8% | -915.4% | · | -1126.6% | -1027.0% | -1133.4% | · | · | · | |
| ROA | -7.3% | -6.0% | · | -6.3% | -13.4% | -7.5% | · | -13.9% | · | |
| ROE | -7.8% | -6.4% | · | -6.8% | -14.6% | -8.3% | · | -14.9% | · |
流动性与偿付能力 4
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 17.2 | 24.8 | · | 11.9 | 13.2 | 13.7 | · | 17.6 | · | |
| Quick Ratio | 16.6 | 24.3 | · | 11.7 | 13.0 | 13.5 | · | 17.5 | · | |
| Debt / Equity | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | · | |
| LT Debt / Equity | · | · | · | 0.0 | 0.0 | 0.0 | · | 0.0 | · |
效率 2
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | · | · | |
| Receivables Turnover | 4.0 | 5.2 | · | 8.0 | 8.0 | 8.0 | · | · | · |
估值 (TTM) 14
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $10M | $9M | · | $6M | $4M | · | · | · | · | |
| Net Income TTM | $-90M | $-77M | · | $-78M | $-71M | $-63M | · | $-65M | · | |
| Market Cap | $1.12B | $776M | · | $211M | $148M | $135M | · | $711M | · | |
| Enterprise Value | $803M | $394M | · | $-71M | $-144M | $-179M | · | $387M | · | |
| P/E | -10.8 | -8.6 | · | -0.7 | -0.3 | -0.2 | · | -0.7 | · | |
| P/S | 115.8 | 89.3 | · | 35.6 | 38.3 | · | · | · | · | |
| P/B | 3.0 | 2.0 | · | 0.8 | 0.5 | 0.4 | · | 2.3 | · | |
| P / Tangible Book | 3.0 | 2.0 | · | 0.8 | 0.5 | 0.4 | · | 2.3 | · | |
| P / Cash Flow | · | -32.3 | · | · | · | -7.8 | · | · | · | |
| P / FCF | · | -32.3 | · | · | · | -7.6 | · | · | · | |
| EV / EBITDA | -27.4 | -15.5 | · | 3.1 | 5.8 | 10.9 | · | -15.6 | · | |
| EV / FCF | · | -16.4 | · | · | · | 10.0 | · | · | · | |
| EV / Revenue | 82.9 | 45.4 | · | -12.0 | -37.2 | · | · | · | · | |
| Earnings Yield | -9.2% | -11.7% | · | -139.8% | -377.7% | -605.3% | · | -149.7% | · |
财务报表 损益表、资产负债表、现金流量表 — 年度，近5年
损益表
| 2025-12-31 | 2024-12-31 | 2023-12-31 | |
|---|---|---|---|
| 收入 | $9M | $0 | — |
| 营业利润率 % | -1031.5% | — | — |
| 净收入 | $-81M | $-71M | $-64M |
| 稀释后每股收益 (EPS) | $-2.24 | $-6.63 | $-38.17 |
资产负债表
| 2025-12-31 | 2024-12-31 | 2023-12-31 | |
|---|---|---|---|
| 负债/股东权益比率 | 0.0 | 0.0 | — |
| 流动比率 | 14.2 | 12.9 | — |
| 速动比率 | 14.0 | 12.8 | — |
现金流
| 2025-12-31 | 2024-12-31 | 2023-12-31 | |
|---|---|---|---|
| 自由现金流 | $-82M | $-52M | — |
我的指标 您的个人关注列表 — 来自完整基本面的选定行
📊
选择对您重要的指标 — 点击上方完整基本面中任意行的 ➕。
您的选择已保存，并会跟随您浏览所有股票。
机构持有人 (13F) 169 家申报者 · $825.4M 总计 · 截至 2026年6月30日
在其季度SEC表格13F中报告持有此股票的机构。仅限多头头寸；单个申报人可能因单独的期权腿而出现两次。 大的抵消性看跌/看涨腿通常反映做市或对冲库存，而非方向性判断。
机构活动 — Q2 2026 与上一季度对比
| 新仓位 | 已退出持仓 | 增加 | 减少 | 净股数变动 |
|---|---|---|---|---|
| 42 (-7 与上一季度对比) | 19 (+3 与上一季度对比) | 51 (+7 与上一季度对比) | 43 (+18 与上一季度对比) | +3.0M |
与Q1 2026对比。 SEC 13F表格的提交截止日期是季度末后45天，外加少量延迟提交的缓冲期——在此窗口期内的季度将被跳过，优先显示最近一个已完整报告的季度对。
| 机构 | 价值 | 股份 | % 已追踪的13F | 类型 |
|---|---|---|---|---|
| a16z Capital Management, L.L.C. | $79244997 | 3233170 | 9.60% | 股份 |
| Cormorant Asset Management, LP | $58593729 | 2390605 | 7.10% | 股份 |
| Sofinnova Investments, Inc. | $56220744 | 2293788 | 6.81% | 股份 |
| Octagon Capital Advisors LP | $42843480 | 1748000 | 5.19% | 股份 |
| RA CAPITAL MANAGEMENT, L.P. | $40972092 | 1671648 | 4.96% | 股份 |
| MPM BIOIMPACT LLC | $40874371 | 1667661 | 4.95% | 股份 |
| VANGUARD CAPITAL MANAGEMENT LLC | $37848685 | 1544214 | 4.59% | 股份 |
| JANUS HENDERSON GROUP PLC | $36597368 | 2094270 | 4.43% | 股份 |
| Polar Capital Holdings Plc | $26283151 | 1072344 | 3.18% | 股份 |
| BRAIDWELL LP | $25321992 | 1033129 | 3.07% | 股份 |
| STATE STREET CORP | $25036083 | 1021464 | 3.03% | 股份 |
| GEODE CAPITAL MANAGEMENT, LLC | $21542373 | 878729 | 2.61% | 股份 |
| Sands Capital Alternatives, LLC | $19273512 | 786353 | 2.34% | 股份 |
| ORBIMED ADVISORS LLC | $18435270 | 752153 | 2.23% | 股份 |
| Balyasny Asset Management L.P. | $17227050 | 702858 | 2.09% | 股份 |
| D. E. Shaw & Co., Inc. | $16771139 | 684257 | 2.03% | 股份 |
| VANGUARD GROUP INC | $16418324 | 1240992 | 1.99% | 股份 |
| Pivotal bioVenture Partners Investment Advisor LLC | $16014197 | 653374 | 1.94% | 股份 |
| COSMIC MANAGEMENT, LLC | $12299927 | 501833 | 1.49% | 股份 |
| STEMPOINT CAPITAL LP | $11376831 | 464171 | 1.38% | 股份 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $10053144 | 410165 | 1.22% | 股份 |
| JACOBS LEVY EQUITY MANAGEMENT, INC | $9242353 | 377085 | 1.12% | 股份 |
| DIMENSIONAL FUND ADVISORS LP | $8778158 | 358146 | 1.06% | 股份 |
| Walleye Capital LLC | $8686221 | 354395 | 1.05% | 股份 |
| Integral Health Asset Management, LLC | $7353000 | 300000 | 0.89% | 股份 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | $7353000 | 300000 | 0.89% | 股份 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $7267215 | 296500 | 0.88% | 买入期权 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $6700323 | 273371 | 0.81% | 股份 |
| Comprehensive Financial Management LLC | $6662847 | 271842 | 0.81% | 股份 |
| BANK OF AMERICA CORP /DE/ | $6320026 | 257855 | 0.77% | 股份 |
| Squadron Capital Management LLC | $6127500 | 250000 | 0.74% | 买入期权 |
| MILLENNIUM MANAGEMENT LLC | $5456441 | 222621 | 0.66% | 股份 |
| VANGUARD FIDUCIARY TRUST CO | $5382396 | 219600 | 0.65% | 股份 |
| SPHERA FUNDS MANAGEMENT LTD. | $5237076 | 213671 | 0.63% | 股份 |
| DIADEMA PARTNERS LP | $4904451 | 200100 | 0.59% | 买入期权 |
| Ikarian Capital, LLC | $4901999 | 200000 | 0.59% | 股份 |
| GOLDMAN SACHS GROUP INC | $4599081 | 187641 | 0.56% | 股份 |
| FMR LLC | $4499129 | 183563 | 0.55% | 股份 |
| Yiheng Capital Management, L.P. | $4179739 | 170532 | 0.51% | 股份 |
| MORGAN STANLEY | $4071430 | 166113 | 0.49% | 股份 |
| RENAISSANCE TECHNOLOGIES LLC | $4061307 | 165700 | 0.49% | 股份 |
| Squadron Capital Management LLC | $3799050 | 155000 | 0.46% | 股份 |
| DIADEMA PARTNERS LP | $3586646 | 146334 | 0.43% | 股份 |
| Ensign Peak Advisors, Inc | $3473018 | 141698 | 0.42% | 股份 |
| UBS Group AG | $2522716 | 102926 | 0.31% | 股份 |
| NEXTBio Capital Management LP | $2468941 | 100732 | 0.30% | 股份 |
| Burkehill Global Management, LP | $2451000 | 100000 | 0.30% | 股份 |
| Alessandra Capital Management, LLC | $2288459 | 93368 | 0.28% | 股份 |
| CITADEL ADVISORS LLC | $1920726 | 78365 | 0.23% | 股份 |
| Caption Management, LLC | $1838250 | 75000 | 0.22% | 买入期权 |
| BNP PARIBAS FINANCIAL MARKETS | $1752146 | 71487 | 0.21% | 股份 |
| Birchview Capital, LP | $1691190 | 69000 | 0.20% | 股份 |
| Squarepoint Ops LLC | $1677366 | 68436 | 0.20% | 股份 |
| TWO SIGMA INVESTMENTS, LP | $1504767 | 61394 | 0.18% | 股份 |
| BOOTHBAY FUND MANAGEMENT, LLC | $1504424 | 61380 | 0.18% | 股份 |
| AMERIPRISE FINANCIAL INC | $1450943 | 59198 | 0.18% | 股份 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $1431384 | 58400 | 0.17% | 卖出期权 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $1422193 | 58025 | 0.17% | 股份 |
| AMERICAN CENTURY COMPANIES INC | $1342658 | 54780 | 0.16% | 股份 |
| Quantinno Capital Management LP | $1254618 | 51188 | 0.15% | 股份 |
| SEVEN GRAND MANAGERS, LLC | $1225500 | 50000 | 0.15% | 股份 |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $1214348 | 49545 | 0.15% | 股份 |
| Moody Aldrich Partners LLC | $1164004 | 47491 | 0.14% | 股份 |
| SIMPLEX TRADING, LLC | $1158832 | 47280 | 0.14% | 股份 |
| Bank of New York Mellon Corp | $1118416 | 45631 | 0.14% | 股份 |
| RHUMBLINE ADVISERS | $1076080 | 43904 | 0.13% | 股份 |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | $1029420 | 42000 | 0.12% | 股份 |
| Corient Private Wealth LP | $986724 | 40778 | 0.12% | 股份 |
| BlackRock, Inc. | $985400 | 40204 | 0.12% | 股份 |
| Persistent Asset Partners Ltd | $913071 | 37253 | 0.11% | 股份 |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC | $866183 | 35340 | 0.10% | 股份 |
| DEUTSCHE BANK AG\ | $840644 | 34298 | 0.10% | 股份 |
| ALLIANCEBERNSTEIN L.P. | $799293 | 45700 | 0.10% | 股份 |
| CITADEL ADVISORS LLC | $794124 | 32400 | 0.10% | 卖出期权 |
| Militia Capital Management LLC | $791330 | 32286 | 0.10% | 股份 |
| Vanguard Global Advisers, LLC | $781011 | 31865 | 0.09% | 股份 |
| MARSHALL WACE, LLP | $778021 | 31743 | 0.09% | 股份 |
| WELLINGTON MANAGEMENT GROUP LLP | $735349 | 30002 | 0.09% | 股份 |
| CITIGROUP INC | $697138 | 28443 | 0.08% | 股份 |
| STATE OF WISCONSIN INVESTMENT BOARD | $689883 | 28147 | 0.08% | 股份 |
| CITADEL ADVISORS LLC | $681378 | 27800 | 0.08% | 买入期权 |
| PUBLIC EMPLOYEES RETIREMENT SYSTEM OF OHIO | $681084 | 27788 | 0.08% | 股份 |
| XTX Topco Ltd | $656696 | 26793 | 0.08% | 股份 |
| WEXFORD CAPITAL LP | $631500 | 25765 | 0.08% | 股份 |
| MILLENNIUM MANAGEMENT LLC | $612750 | 25000 | 0.07% | 买入期权 |
| JANE STREET GROUP, LLC | $590421 | 24089 | 0.07% | 股份 |
| Caption Management, LLC | $569612 | 23240 | 0.07% | 股份 |
| STRS OHIO | $539220 | 22000 | 0.07% | 股份 |
| BARCLAYS PLC | $538779 | 21982 | 0.07% | 股份 |
| Militia Capital Partners, LP | $533169 | 40300 | 0.06% | 股份 |
| MetLife Investment Management, LLC | $511989 | 20889 | 0.06% | 股份 |
| Stonepine Capital Management, LLC | $490200 | 20000 | 0.06% | 股份 |
| BANK OF NOVA SCOTIA | $490200 | 20000 | 0.06% | 股份 |
| Man Group plc | $444783 | 18147 | 0.05% | 股份 |
| Virtus Investment Advisers, LLC | $444538 | 18137 | 0.05% | 股份 |
| Verdad Advisers, LP | $426327 | 17394 | 0.05% | 股份 |
| JANE STREET GROUP, LLC | $409317 | 16700 | 0.05% | 卖出期权 |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. | $396743 | 16187 | 0.05% | 股份 |
| GREAT LAKES ADVISORS, LLC | $390493 | 15932 | 0.05% | 股份 |
| Y-Intercept (Hong Kong) Ltd | $373532 | 15240 | 0.05% | 股份 |
公司内部人士 9 位内幕人士 · 3 位高管 · 6 位董事
| 内部人士 | 角色 | 上次活动 | 持股数量 | 买入 12个月 | 卖出 12个月 | 净额 12个月 |
|---|---|---|---|---|---|---|
| GOLDSTEIN DOV A MD | Chief Financial Officer | 2026年4月23日 M | 36575 | 0 | 4 | $-531844 |
| Shane Barton | Principal Accounting Officer | 2026年6月30日 M | 0 | 0 | 2 | $-1576885 |
| Paul D Rubin | Chief Medical Officer | 2026年4月1日 M | 0 | 0 | 6 | $-1460917 |
| Vijay Satyanand Pande | 董事 | 2026年6月10日 A | — | 0 | 0 | $0 |
| Rekha Hemrajani | 董事 | 2026年6月10日 A | — | 0 | 0 | $0 |
| Michael H. Davidson | 董事 | 2026年6月10日 A | — | 0 | 0 | $0 |
| Patrick G. Enright | 董事 | 2026年6月10日 A | — | 0 | 0 | $0 |
| Dr. James I. Healy | 董事 | 2026年6月10日 A | — | 0 | 0 | $0 |
| Jean Pierre Garnier | 董事 | 2026年6月10日 A | — | 0 | 0 | $0 |
来自SEC表格3/4/5申报的内部人士；净额=仅公开市场买卖
激进投资者及 5%+ 股东 2 持仓
提交了 SEC Schedule 13D 的投资者 — 持有超过 5% 的受益所有权，意图影响发行人（激进股东持股、董事会活动、并购）。每一行显示该申报人持仓的最新已知状态。
| 申报人 | 已申报 | 持股 | 状态 | 目的 | 申报 |
|---|---|---|---|---|---|
| AH Bio Fund I, L.P., AH Equity Partners Bio I, L.L.C., AH Bio Fund III, L.P., AH Equity Partners Bio III, L.L.C., AH Bio Fund IV, L.P., AH Equity Partners Bio IV, L.L.C., Andreessen Horowitz LSV Fund III, L.P., AH Equity Partners LSV III, L.L.C., Marc Andreessen, Benjamin Horowitz | 2024年10月4日 | — | 初始申报 | 被动投资 | SEC |
| Sofinnova Venture Partners XI, L.P. (“SVP XI”), Sofinnova Management XI, L.P. (“SM XI LP”), Sofinnova Management XI, L.L.C. (“SM XI LLC”), Dr. James I. Healy (“Healy”), Dr. Maha Katabi (“Katabi”) | 2024年9月30日 | — | 初始申报 | 被动投资 | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
ETF持仓 由 36 只交易所交易基金持有
权重仅反映直接股权持仓（N-PORT）；杠杆基金或基于衍生品的基金可能持有未显示的额外掉期敞口。
| 基金 | 权重 | 单位 | 截至 | 来源 |
|---|---|---|---|---|
| PILL · Direxion Shares ETF Trust | 0.81% | 6165 NS | 2026年4月30日 | N-PORT |
| DWAS · Invesco Exchange-Traded Fund Trus... | 0.26% | 100818 SH | 2026年8月8日 | 每日 |
| VFMO · VANGUARD WELLINGTON FUND | 0.16% | 127778 SH | 2026年8月8日 | 每日 |
| IWC · iShares Trust | 0.09% | 118766 SH | 2026年8月8日 | 每日 |
| IHE · iShares Trust | 0.08% | 113984 SH | 2026年8月8日 | 每日 |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0.05% | 27617 SH | 2026年8月8日 | 每日 |
| BIB · ProShares Trust | 0.04% | 1604 NS | 2026年5月31日 | N-PORT |
| IBBQ · Invesco Exchange-Traded Fund Trus... | 0.04% | 2418 SH | 2026年8月8日 | 每日 |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0.03% | 202410 SH | 2026年8月8日 | 每日 |
| IBB · iShares Trust | 0.03% | 230833 SH | 2026年8月8日 | 每日 |
| AVSC · AMERICAN CENTURY ETF TRUST | 0.03% | 43526 NS | 2026年5月31日 | N-PORT |
| IWN · iShares Trust | 0.02% | 293863 SH | 2026年8月8日 | 每日 |
| GSSC · Goldman Sachs ETF Trust | 0.02% | 10835 NS | 2026年5月31日 | N-PORT |
| RSSL · Global X Funds | 0.02% | 13075 NS | 2026年4月30日 | N-PORT |
| ITWO · ProShares Trust | 0.01% | 1420 NS | 2026年5月31日 | N-PORT |
| IWM · iShares Trust | 0.01% | 897031 SH | 2026年8月8日 | 每日 |
| SCHA · SCHWAB STRATEGIC TRUST | 0.01% | 142676 NS | 2026年5月31日 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0.01% | 367869 SH | 2026年8月8日 | 每日 |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0.01% | 3710 SH | 2026年8月8日 | 每日 |
| DFAS · Dimensional ETF Trust | 0.01% | 79583 NS | 2026年4月30日 | N-PORT |
| UWM · ProShares Trust | 0.01% | 1111 NS | 2026年5月31日 | N-PORT |
| URTY · ProShares Trust | 0.01% | 1121 NS | 2026年5月31日 | N-PORT |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0.00% | 12106 SH | 2026年8月8日 | 每日 |
| ONEQ · Fidelity Commonwealth Trust | 0.00% | 20675 NS | 2026年5月31日 | N-PORT |
| IWO · iShares Trust | 0.00% | 31584 SH | 2026年8月8日 | 每日 |
| HDG · ProShares Trust | 0.00% | 28 NS | 2026年5月31日 | N-PORT |
| DCOR · Dimensional ETF Trust | 0.00% | 1850 NS | 2026年4月30日 | N-PORT |
| SCHB · SCHWAB STRATEGIC TRUST | 0.00% | 16108 NS | 2026年5月31日 | N-PORT |
| ITOT · iShares Trust | 0.00% | 45805 SH | 2026年8月8日 | 每日 |
| IWV · iShares Trust | 0.00% | 8951 SH | 2026年8月8日 | 每日 |
| DFAC · Dimensional ETF Trust | 0.00% | 13304 NS | 2026年4月30日 | N-PORT |
| AVUS · AMERICAN CENTURY ETF TRUST | 0.00% | 1959 NS | 2026年5月31日 | N-PORT |
| DFUS · Dimensional ETF Trust | 0.00% | 2074 NS | 2026年4月30日 | N-PORT |
| DFAU · Dimensional ETF Trust | 0.00% | 893 NS | 2026年4月30日 | N-PORT |
| VTI · VANGUARD INDEX FUNDS | 0.00% | 1140593 SH | 2026年8月8日 | 每日 |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0.00% | 2774 SH | 2026年8月8日 | 每日 |